The types of Laser Atherectomy Devices further refine the market taxonomy, delineating technology pathways that influence adoption and pricing dynamics. Excimer laser atherectomy—utilizing pulsed ultraviolet photons—captures the majority of the market, estimated at 60 % of device revenue, because of its proven efficacy in ablating both soft plaque and calcium with minimal thermal injury. Diode laser atherectomy, representing approximately 25 % of sales, offers a more compact, cost‑effective platform suited for peripheral interventions, though its penetration depth is lower than excimer systems. Fiber laser atherectomy, a newer entrant, holds about 15 % of the market; it delivers high‑energy infrared beams through flexible fiber optics, enabling precise plaque removal in tortuous anatomy and attracting early adopters in coronary applications. Each type’s contribution to the overall market size reflects its clinical performance profile, regulatory approvals, and manufacturer R&D investment, providing stakeholders with a granular view of technology‑driven growth within the Laser Atherectomy Devices market.